| Name | Title | Contact Details |
|---|
Community Medical Services is a CARF–accredited addiction treatment program providing services in the form of outpatient medication-assisted treatment and private one–on–one and group counseling, Intensive Out-Patient therapy (IOP) and Moral Reconation Therapy (MRT) to those seeking help with their substance use disorders. We have a total of 14 clinics throughout the United States. We have seven Arizona locations which cater to Phoenix, Glendale, Mesa, Scottsdale, and Tempe; a clinic in East Tucson, Northwest Tucson, Safford and Casa Grande; four clinics in Montana located in Missoula, Kalispell, Billings and Belgrade, which cater to clients in Bozeman and Helena; a clinic in Wasilla, Alaska catering to the Mat-Su Valley and Anchorage, and two clinics in North Dakota, one located in Minot, catering to clients in Williston and Bismarck and a clinic in Fargo, catering to clients from Fargo/Moorhead, West Fargo, Grand Forks, and Minnesota.
US Re Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Houston, TX. To find more information about US Re Corporation, please visit www.usre.com
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.
vision orlando inc is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).